Pulmonary alveolar proteinosis in rats after administration of quartz: its possible role in morphogenesis of lung cancer

Abstract

In rats, primary peripheral lung tumors composed predominantly of alveolar type II cells have been induced by inhalation of α quartz. In our retrospective study on proliferation markers we evaluated lung specimens of 140 Wistar rats from larger experiments, which had been exposed to Dörentrup quartz (DQ12) by inhalation (10 mg/m³, 56 Weeks, 5 days/week, 7 h/day:n=27) or intratracheal instillations (5 mg:n=38; 20 mg:n=10; 50 mg:n=28; 15×3 mg:n=12). In the last group 8/12 animals developed lung tumors. Animals were sacrificed 1–32 months after administration. For identification of an increased proliferation of alveolar type II cells the DNA content was monitored by microscopic (static) cytophotometry in histological slides. The argyrophil (AgNOR) method for the demonstration of nucleolar organizer regions (NOR) was used as second marker of type II cell proliferation. Measurements made 24 months after inhalation of DQ12 showed a slight increase of pneumocytic proliferation with 1.64±0.14 AgNOR/nucleus compared to the controls (1.23±0.04 mean AgNOR/nucleus). After intratracheal instillation of DQ12 a significant increase of AgNOR was found, e.g. 5 mg: 1.93±0.23 AgNOR/nucleus (6 months) and 1.96±0.19 (12 months); 50 mg: 1.77±0.15 (6 months) and 2.18±0.05 (12 months); 15×3 mg (+2 ml 2% polyvinylpyridineN-oxide s.c.): 1.81±0.13 AgNOR/nucleus (27–32 months). With the aid of the 2c deviation index, i.e. the mean square deviation from the diploid DNA value, it was possible also to identify the pathologically increased proliferation of type II cells after intratracheal instillation of quartz: 0.02±0.01−0.06±0.04c ² (controls); 0.07±0.04c ² (5 mg/12 months); 0.12±0.08c ² (15×3 mg/>27 months) and 0.68±0.48c ₂ (50 mg/12 months). Only in the last group were nearly triploid values detected. Summarizing our results, intratracheal instillation and inhalation of quartz in rats regularly induces alveolar proteinosis and interstitial fibrosis in combination with a dose- and time-dependent increase of the type II cell proliferation rate. As mitogenesis increases carcinogenesis, alveolar proteinosis with increased pneumocytic proliferative activity might be a prerequisite for enhanced tumor development.